Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

564 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
[Effects of statin use on intracranial hemorrhage and clinical outcome after intravenous rt-PA for acute ischemic stroke: SAMURAI rt-PA registry].
Makihara N, Okada Y, Koga M, Shiokawa Y, Nakagawara J, Furui E, Kimura K, Yamagami H, Hasegawa Y, Kario K, Okuda S, Naganuma M, Toyoda K. Makihara N, et al. Among authors: shiokawa y. Rinsho Shinkeigaku. 2010 Apr;50(4):225-31. doi: 10.5692/clinicalneurol.50.225. Rinsho Shinkeigaku. 2010. PMID: 20411804 Japanese.
Intravenous thrombolysis for patients with reverse magnetic resonance angiography and diffusion-weighted imaging mismatch: SAMURAI and NCVC rt-PA Registries.
Sakamoto Y, Koga M, Kimura K, Nagatsuka K, Okuda S, Kario K, Hasegawa Y, Okada Y, Yamagami H, Furui E, Nakagawara J, Shiokawa Y, Okata T, Kobayashi J, Tanaka E, Minematsu K, Toyoda K. Sakamoto Y, et al. Among authors: shiokawa y. Eur J Neurol. 2014 Mar;21(3):419-26. doi: 10.1111/ene.12308. Epub 2013 Nov 22. Eur J Neurol. 2014. PMID: 24261412
Reduced estimated glomerular filtration rate is associated with stroke outcome after intravenous rt-PA: the Stroke Acute Management with Urgent Risk-Factor Assessment and Improvement (SAMURAI) rt-PA registry.
Naganuma M, Koga M, Shiokawa Y, Nakagawara J, Furui E, Kimura K, Yamagami H, Okada Y, Hasegawa Y, Kario K, Okuda S, Nishiyama K, Minematsu K, Toyoda K. Naganuma M, et al. Among authors: shiokawa y. Cerebrovasc Dis. 2011;31(2):123-9. doi: 10.1159/000321516. Epub 2010 Nov 17. Cerebrovasc Dis. 2011. PMID: 21088392 Free article.
CHADS2 score is associated with 3-month clinical outcomes after intravenous rt-PA therapy in stroke patients with atrial fibrillation: SAMURAI rt-PA Registry.
Koga M, Kimura K, Shibazaki K, Shiokawa Y, Nakagawara J, Furui E, Yamagami H, Okada Y, Hasegawa Y, Kario K, Okuda S, Naganuma M, Nezu T, Maeda K, Minematsu K, Toyoda K. Koga M, et al. Among authors: shiokawa y. J Neurol Sci. 2011 Jul 15;306(1-2):49-53. doi: 10.1016/j.jns.2011.03.046. Epub 2011 Apr 14. J Neurol Sci. 2011. PMID: 21492878
Early ischemic change on CT versus diffusion-weighted imaging for patients with stroke receiving intravenous recombinant tissue-type plasminogen activator therapy: stroke acute management with urgent risk-factor assessment and improvement (SAMURAI) rt-PA registry.
Nezu T, Koga M, Nakagawara J, Shiokawa Y, Yamagami H, Furui E, Kimura K, Hasegawa Y, Okada Y, Okuda S, Kario K, Naganuma M, Maeda K, Minematsu K, Toyoda K. Nezu T, et al. Among authors: shiokawa y. Stroke. 2011 Aug;42(8):2196-200. doi: 10.1161/STROKEAHA.111.614404. Epub 2011 Jun 30. Stroke. 2011. PMID: 21719764
Relative systolic blood pressure reduction and clinical outcomes in hyperacute intracerebral hemorrhage: the SAMURAI-ICH observational study.
Sakamoto Y, Koga M, Todo K, Okuda S, Okada Y, Kimura K, Shiokawa Y, Kamiyama K, Furui E, Hasegawa Y, Kario K, Okata T, Kobayashi J, Tanaka E, Yamagami H, Nagatsuka K, Minematsu K, Toyoda K; SAMURAI study investigators. Sakamoto Y, et al. Among authors: shiokawa y. J Hypertens. 2015 May;33(5):1069-73. doi: 10.1097/HJH.0000000000000512. J Hypertens. 2015. PMID: 25668358
Routine use of intravenous low-dose recombinant tissue plasminogen activator in Japanese patients: general outcomes and prognostic factors from the SAMURAI register.
Toyoda K, Koga M, Naganuma M, Shiokawa Y, Nakagawara J, Furui E, Kimura K, Yamagami H, Okada Y, Hasegawa Y, Kario K, Okuda S, Nishiyama K, Minematsu K; Stroke Acute Management with Urgent Risk-factor Assessment and Improvement Study Investigators. Toyoda K, et al. Among authors: shiokawa y. Stroke. 2009 Nov;40(11):3591-5. doi: 10.1161/STROKEAHA.109.562991. Epub 2009 Sep 17. Stroke. 2009. PMID: 19762694
Low-dose intravenous recombinant tissue-type plasminogen activator therapy for patients with stroke outside European indications: Stroke Acute Management with Urgent Risk-factor Assessment and Improvement (SAMURAI) rtPA Registry.
Koga M, Shiokawa Y, Nakagawara J, Furui E, Kimura K, Yamagami H, Okada Y, Hasegawa Y, Kario K, Okuda S, Endo K, Miyagi T, Osaki M, Minematsu K, Toyoda K. Koga M, et al. Among authors: shiokawa y. Stroke. 2012 Jan;43(1):253-5. doi: 10.1161/STROKEAHA.111.631176. Epub 2011 Sep 29. Stroke. 2012. PMID: 21960585
564 results